| Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. | |
| | |
MedLine Citation:
|
PMID: 20559035 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: HIV-1 replication and microbial translocation occur concomitant with systemic immune activation. This study delineates mechanisms of immune activation and CD4 T-cell decline in pediatric HIV-1 infection. DESIGN: Cross-sectional and longitudinal cellular and soluble plasma markers for inflammation were evaluated in 14 healthy and 33 perinatally HIV-1-infected pediatric study volunteers prior to and over 96 weeks of protease-inhibitor-containing combination antiretroviral therapy (ART). All HIV-1-infected patients reconstituted CD4 T cells either with suppression of viremia or rebound of drug-resistant virus. METHODS: Systemic immune activation was determined by polychromatic flow cytometry of blood lymphocytes and ELISA for plasma soluble CD27, soluble CD14, and tumor necrosis factor. Microbial translocation was evaluated by limulus amebocyte lysate assay to detect bacterial lipopolysaccharide (LPS) and ELISA for antiendotoxin core antigen immunoglobulin M (IgM) antibodies. Immune activation markers were compared with viral load, CD4 cell percentage, and LPS by regression models. Comparisons between healthy and HIV-1-infected or between different viral outcome groups were performed by nonparametric rank sum. RESULTS: Microbial translocation was detected in healthy infants but resolved with age (P < 0.05). LPS and soluble CD14 levels were elevated in all HIV-1-infected patients (P < 0.05 and P < 0.0001, respectively) and persisted even if CD4 T cells were fully reconstituted, virus optimally suppressed, and lymphocyte activation resolved by ART. Children with CD4 T-cell reconstitution but viral rebound following ART continued to display high levels of soluble CD27. CONCLUSION: Microbial translocation in pediatric HIV-1 infection is associated with persistent monocyte/macrophage activation independent of viral replication or T-cell activation. |
| | |
Authors:
|
Mark A Wallet; Carina A Rodriguez; Li Yin; Sara Saporta; Sasawan Chinratanapisit; Wei Hou; John W Sleasman; Maureen M Goodenow |
Related Documents
:
|
7594725 - Interaction with human immunodeficiency virus type 1 modulates innate effector function... 16043695 - Hiv-1 nef down-regulates the hemochromatosis protein hfe, manipulating cellular iron ho... 12521275 - Disease progression markers during asymptomatic phase of hiv-1 infected children with u... 8336945 - Evidence for stimulation of the transforming growth factor beta 1 promoter by hiv-1 tat... 8467805 - Programmed cell death by bcl-2-dependent and independent mechanisms in b lymphoma cells. 17535975 - Tumoricidal activity of tlr7/8-activated inflammatory dendritic cells. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: AIDS (London, England) Volume: 24 ISSN: 1473-5571 ISO Abbreviation: AIDS Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-06-18 Completed Date: 2010-12-30 Revised Date: 2011-07-28 |
Medline Journal Info:
|
Nlm Unique ID: 8710219 Medline TA: AIDS Country: England |
Other Details:
|
Languages: eng Pagination: 1281-90 Citation Subset: IM; X |
Affiliation:
|
Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Antigens, CD14 / blood Antigens, CD27 / blood Antiretroviral Therapy, Highly Active Bacterial Translocation* CD4 Lymphocyte Count Child Child, Preschool Cross-Sectional Studies Female HIV Infections / blood, drug therapy, immunology* HIV-1 / immunology, physiology* Humans Infant Macrophage Activation / immunology* Male Tumor Necrosis Factor-alpha / blood Viral Load Virus Replication / immunology* |
| Grant Support | |
ID/Acronym/Agency:
|
AI047723/AI/NIAID NIH HHS; AI065265/AI/NIAID NIH HHS; HD032259/HD/NICHD NIH HHS; R01 AI065265-05/AI/NIAID NIH HHS; R01 HD032259-13/HD/NICHD NIH HHS; T32 AR007603/AR/NIAMS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, CD14; 0/Antigens, CD27; 0/Tumor Necrosis Factor-alpha |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza...
Next Document: Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying disea...